TASIGNA

TASIGNA

nilotinib

Manufacturer:

Novartis Pharma
Basic Prescribing Info
Contents
nilotinib hydrochloride monohydrate.
Administration
Should be taken on an empty stomach. Avoid food at least 2 hr before & at least 1 hr after a dose. Swallow whole, do not chew/crush. Avoid grapefruit products.
CIMS Class
Targeted Cancer Therapy
ATC Classification
L01EA03 - nilotinib
Presentation/Packing
Form
TASIGNA cap
Packing/Price
150 mg x 28's (58,800 INR);150 mg x 4's (8,000 INR);200 mg x 28's (58,800 INR);200 mg x 4's (8,505.57 INR)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in